These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 35606755)

  • 41. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-Methylcytosine-related lncRNAs: predicting prognosis and identifying hot and cold tumor subtypes in head and neck squamous cell carcinoma.
    Huang J; Xu Z; Zhou C; Cheng L; Zeng H; Shen Y
    World J Surg Oncol; 2023 Jun; 21(1):180. PubMed ID: 37312123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploration of Novel Immunological Terms in Lung Cancer With Large Populations: Implications for Immunotherapy.
    Yao Y; Wang J; Yang F; Gao W
    Front Immunol; 2022; 13():924498. PubMed ID: 35844536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
    Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
    Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
    Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
    Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.
    Zhong R; Zhan J; Zhang S
    Appl Biochem Biotechnol; 2024 Jul; 196(7):3891-3913. PubMed ID: 37792175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrative machine learning and neural networks for identifying PANoptosis-related lncRNA molecular subtypes and constructing a predictive model for head and neck squamous cell carcinoma.
    Wang Z; Cheng L; Huang J; Shen Y
    Eur Arch Otorhinolaryngol; 2024 Oct; 281(10):5481-5495. PubMed ID: 38914821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment.
    Wang X; Cao K; Guo E; Mao X; An C; Guo L; Zhang C; Guo J; Yang X; Sun J; Yang W; Li X; Miao S
    Cancer Immunol Immunother; 2022 May; 71(5):1199-1220. PubMed ID: 34643766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction of Immune Infiltration-Related LncRNA Signatures Based on Machine Learning for the Prognosis in Colon Cancer.
    Liu Z; Petinrin OO; Toseef M; Chen N; Wong KC
    Biochem Genet; 2024 Jun; 62(3):1925-1952. PubMed ID: 37792224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway.
    Zhu Q; Zhang X; Lu F; Miao S; Zhang C; Liu Z; Gao Z; Qi M; An X; Geng P; Wang S; Ren H; Han F; Zhang R; Zha D
    Cell Commun Signal; 2024 Apr; 22(1):227. PubMed ID: 38610001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
    Lai J; Chen B; Zhang G; Li X; Mok H; Liao N
    J Transl Med; 2020 Nov; 18(1):416. PubMed ID: 33160384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.
    Hong X; Li Y; Lv Q; An J; Liu Y; Wang X; Li R; Hu Y; Liu B
    Int J Immunopathol Pharmacol; 2023; 37():3946320231172075. PubMed ID: 37073715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miRNA-Based Feature Classifier Is Associated with Tumor Mutational Burden in Head and Neck Squamous Cell Carcinoma.
    Xia Y; Wang Q; Huang X; Yin X; Song J; Ke Z; Duan X
    Biomed Res Int; 2020; 2020():1686480. PubMed ID: 33490233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma.
    Chen X; Cai Q; Wong K; Shen X; Guan Z
    Heliyon; 2024 Feb; 10(3):e25266. PubMed ID: 38352733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
    Zhang S; Zhang W; Zhang J
    Oral Oncol; 2022 Mar; 126():105755. PubMed ID: 35144208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma.
    Huang Y; Liu H; Liu B; Chen X; Li D; Xue J; Li N; Zhu L; Yang L; Xiao J; Liu C
    BMC Med Genomics; 2024 Feb; 17(1):49. PubMed ID: 38331768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.